Experimental COVID-19 vaccine at Imperial College London: Human testing has begun and royalties will be waived
-
Last Update: 2020-07-12
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
The experimentalCOVID-19vaccine at Imperial College London has been infusions to the first healthy volunteer at a west London facilityIn this trial, about 300 people will receive the vaccine and be vaccinated within four weeks of the first injectionIf the experimental COVID-19 vaccine is safe and effective in inducing a humanimmuneresponse, the vaccine will be tested on a larger scale later this year"We are now ready to test the vaccine at the dose assessment stage before proceeding with a larger assessment," said lead researcher Dr Katrina Pollock, whothe Department of Infectious Diseases at Imperial College London at theImperial College London recently partnered with Morningside Ventures to create a new social enterprise, VacEquity Global Health (VGH), to accelerate vaccine development and expand its global presenceImperial College London and VGH will forgo royalties and charge modest cost prices only in low-income countries in the UK and abroad to accelerate global distribution of the COVID-19 vaccine and support new research
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
